Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01208766. IPD Sharing: Not stated. Countries: 16. Publications: 5.
Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00657488. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)
ClinicalTrials.gov study NCT04721002. IPD Sharing: UNDECIDED. Countries: 22. Publications: 1.
Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04163107. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00416273. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
ClinicalTrials.gov study NCT04108195. IPD Sharing: YES. Countries: 5. Publications: 2.
Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma
ClinicalTrials.gov study NCT03428373. IPD Sharing: NO. Countries: 1. Publications: 8.
Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients
ClinicalTrials.gov study NCT00406978. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma
ClinicalTrials.gov study NCT06768489. IPD Sharing: YES. Countries: 4. Publications: 1.
Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT00358020. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00291538. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis
ClinicalTrials.gov study NCT06971380. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment
ClinicalTrials.gov study NCT06109233. IPD Sharing: UNDECIDED. Countries: 1. Publications: 26.
A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04696809. IPD Sharing: YES. Countries: 1. Publications: 1.
Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03143985. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)
ClinicalTrials.gov study NCT00773838. IPD Sharing: YES. Countries: 0. Publications: 1.
BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01638936. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.
ClinicalTrials.gov study NCT00330759. IPD Sharing: Not stated. Countries: 0. Publications: 9.
90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01503242. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma
ClinicalTrials.gov study NCT03891914. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.